Industry Webinar: Ex Vivo Lung Perfusion Consensus: European and American Perspectives

Ex vivo lung perfusion (EVLP) has emerged as a transformative technique in lung transplantation, offering new possibilities for organ preservation and assessment. Despite its success, transplant centers worldwide face critical decisions in determining which lungs are suitable for EVLP. This webinar brings together leading experts from Europe and the US to discuss two pivotal consensus documents that guide these decisions. This webinar will explore the differences between the European and American approaches on selecting allografts for EVLP and the implications for resource utilization and clinical outcomes.

Moderator:

Pedro Catarino, MD

Presentations: 

Introduction

Pedro Catarino, MD

Cedars-Sinai

Los Angeles, CA USA

European Society of Organ Transplantation (ESOT) Consensus Statement on Machine Perfusion in Cardiothoracic Transplant

Marius Berman, MD, FRCS (CTh)

Royal Papworth Hospital

Cambridge, UK

North American Expert Consensus on the Clinical Role of Ex Vivo Lung Perfusion (EVLP) With Acellular Perfusate

Matthew Bacchetta, MD

Vanderbilt University Medical Center

Nashville, TN USA

Discussion evaluating the differences between the two publications 

Kenneth McCurry, MD

Cleveland Clinic

Cleveland, OH USA

Panel Discussion